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ABSTRACT
Background: Refeeding syndrome is a potentially life-
threatening condition characterised by severe
intracellular electrolyte shifts, acute circulatory fluid
overload and organ failure. The initial symptoms are
non-specific but early clinical features are severely low-
serum electrolyte concentrations of potassium,
phosphate or magnesium. Risk factors for the
syndrome include starvation, chronic alcoholism,
anorexia nervosa and surgical interventions that require
lengthy periods of fasting. The causes of the refeeding
syndrome are excess or unbalanced enteral, parenteral
or oral nutritional intake. Prevention of the syndrome
includes identification of individuals at risk, controlled
hypocaloric nutritional intake and supplementary
electrolyte replacement.
Objective: To determine the occurrence of refeeding
syndrome in adults commenced on artificial nutrition
support.
Design: Prospective cohort study.
Setting: Large, single site university teaching hospital.
Recruitment period 2007–2009.
Participants: 243 adults started on artificial nutrition
support for the first time during that admission
recruited from wards and intensive care.
Main outcome measures: Primary outcome:
occurrence of the refeeding syndrome. Secondary
outcome: analysis of the risk factors which predict the
refeeding syndrome. Tertiary outcome: mortality due to
refeeding syndrome and all-cause mortality.
Results: 133 participants had one or more of the
following risk factors: body mass index <16–
18.5≥(kg/m2), unintentional weight loss >15% in the
preceding 3–6 months, very little or no nutritional intake
>10 days, history of alcohol or drug abuse and low
baseline levels of serum potassium, phosphate or
magnesium prior to recruitment. Poor nutritional intake
for more than 10 days, weight loss >15% prior to
recruitment and low-serum magnesium level at baseline
predicted the refeeding syndrome with a sensitivity of
66.7%: specificity was >80% apart from weight loss of
>15% which was 59.1%. Baseline low-serum
magnesium was an independent predictor of the
refeeding syndrome (p=0.021). Three participants
(2% 3/243) developed severe electrolyte shifts, acute
circulatory fluid overload and disturbance to organ
function following artificial nutrition support and were
diagnosed with refeeding syndrome. There were no
deaths attributable to the refeeding syndrome, but (5.3%
13/243) participants died during the feeding period and
(28% 68/243) died during hospital admission. Death of
these participants was due to cerebrovascular accident,
traumatic injury, respiratory failure, organ failure or end-
of-life causes.
Conclusions: Refeeding syndrome was a rare,
survivable phenomenon that occurred during hypocaloric
nutrition support in participants identified at risk.
Independent predictors for refeeding syndrome were
starvation and baseline low-serum magnesium
concentration. Intravenous carbohydrate infusion prior to
artificial nutrition support may have precipitated the
onset of the syndrome.
ARTICLE SUMMARY
Article focus
▪ Hypothesis: the risk factors for refeeding syn-
drome are weak and cause unnecessary delay of
nutrition.
▪ Research question: which risk factors reliably
predict development of the refeeding syndrome?
Key messages
▪ The refeeding syndrome is a complex constella-
tion of major characteristics which requires a
multifacet diagnostic criteria.
▪ The refeeding syndrome is a rare, survivable
phenomena that can occur despite identification
of risk and hypocaloric nutritional treatment.
▪ Intravenous glucose infusion prior to artificial
nutrition support can precipitate the refeeding
syndrome.
▪ Starvation is the most reliable predictor for onset
of the syndrome.
Strengths and limitations of this study
▪ The authors were not involved in the nutritional
treatment, electrolyte supplementation or diagno-
sis of refeeding syndrome.
▪ The diagnostic criteria provided unequivocal con-
firmation of the refeeding syndrome and omitted
borderline results.
▪ The main source of data loss was the excluded
group which may potentially have contained par-
ticipants who went on to develop the refeeding
syndrome.
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INTRODUCTION
Refeeding syndrome has been deﬁned as severe ﬂuid and
electrolyte shift in malnourished patients during oral,
enteral or parenteral refeeding.1 A key risk factor for the
syndrome is starvation with early published reports being
prisoners of war.2 In recent times, refeeding syndrome
has been conﬁrmed in hunger strikers, individuals with
anorexia nervosa and chronic alcoholics. The modern
deﬁnition of refeeding syndrome is life-threatening,
severely low-serum electrolyte concentrations, ﬂuid and
electrolyte imbalance and disturbance of organ function
resulting from over-rapid or unbalanced nutrition
support.3 However, this deﬁnition is imprecise and lacks
deﬁnitive electrolyte threshold values to conﬁdently diag-
nose the refeeding syndrome.
The metabolic shift from starvation to feeding increases
cellular uptake of glucose, potassium, phosphate and mag-
nesium which lowers the serum concentration of these
electrolytes.4 The early signs of the refeeding syndrome
are non-speciﬁc but include severely low-serum electrolyte
concentrations of serum phosphate, potassium and mag-
nesium which, if untreated, can progress to acute circula-
tory ﬂuid overload, respiratory compromise and cardiac
failure.5 Severe hypophosphataemia has been described as
the hallmark of the refeeding syndrome.
Guidelines for the prevention and treatment of refeed-
ing syndrome advise identiﬁcation of individuals at risk,
controlled hypocaloric nutritional treatment and supple-
mentary electrolytes.3 However, not all individuals with
risk factors for refeeding syndrome develop symptoms
during nutritional repletion.6 A potential consequence
of adherence to these untested guidelines is the delay of
adequate nutrition to undernourished individuals. We
conducted a prospective cohort study to determine the
occurrence of refeeding syndrome in adults started on
artiﬁcial nutrition support. Refeeding syndrome was con-
ﬁrmed using a three-facet diagnostic criteria of deﬁned
severely low-serum electrolyte concentrations, acute cir-
culatory ﬂuid overload and organ dysfunction.
METHODS
Study design
This was a prospective cohort study conducted at a large,
single-site university teaching hospital. Criteria to deter-
mine risk of refeeding syndrome is displayed in table 1.
The risk factors were body mass index <16 (kg/m2), unin-
tentional weight loss >15% in the preceding 3–6 months,
very little or no nutritional intake for more than 10 days
and low levels of serum potassium, phosphate or magne-
sium prior to artiﬁcial nutrition support. The three-facet
diagnostic criteria used by the research team to conﬁrm
refeeding syndrome is displayed in table 2. Each partici-
pant’s medical team diagnosed the refeeding syndrome
using serum electrolyte shifts and observed clinical com-
plications of acute circulatory ﬂuid overload and organ
dysfunction. The medical teams documented this infor-
mation in the participant’s medical record as daily
clinical observations and treatment. The research team
used the participant’s medical record to conﬁrm that
symptoms occurred from the onset of artiﬁcial nutrition
support recording observations daily and serum electro-
lyte concentrations every third day from baseline. For
each participant diagnosed with the refeeding syndrome,
the research team compared the serum electrolyte con-
centrations, the acute circulatory ﬂuid overload and
organ dysfunction against the three-facet diagnostic cri-
teria. All three facets of the diagnostic criteria were
required by the research team to unequivocally conﬁrm
the diagnosis of refeeding syndrome. To avoid any poten-
tial bias, the authors were not involved in nutritional
treatment, electrolyte supplementation or the initial diag-
nosis of refeeding syndrome during the study period.
The schematic for participant exclusion, recruitment and
analysis is displayed in ﬁgure 1.
Sample size
The sample size was estimated from the reported
prevalence of the refeeding syndrome, deﬁned as hypo-
phosphataemia <0.4 mmol/l, to be 1–10%.7 8 A cohort of
240 would produce between 2 and 24 potential partici-
pants meeting the diagnostic criteria.
Table 1 Criteria for determination of refeeding syndrome
risk3
One of the following: Two of the following:
BMI<16 (kg/m2) BMI<18.5 (kg/m2)
Unintentional weight loss
>15% in the preceding
3–6 months
Unintentional weight loss
>10% in the preceding
3–6 months
Very little or no nutritional
intake for more than 10 days
Very little or no nutritional
intake for more than 5 days
Low levels of serum
potassium, phosphate or
magnesium prior to feed
History of alcohol or drug
abuse
Table 2 Criteria for confirmation of refeeding syndrome
from the start of artificial nutrition support
1. Electrolytes Severely low electrolyte
concentrations4
Potassium <2.5 mmol/l*
Phosphate <0.32 mmol/l
Magnesium <0.5 mmol/l
2. Peripheral oedema or acute
circulatory fluid overload
3. Disturbance to organ
function including respiratory
failure, cardiac failure and
pulmonary oedema
*King’s College Hospital: severely low-serum potassium
concentration which required supplementation.
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Participants
Participants, started on enteral or parenteral artiﬁcial
nutrition support, were eligible to be recruited if they
met the inclusion criteria. The inclusion criteria was
adults >18 years of age started on artiﬁcial nutrition
support for the ﬁrst time during that hospital admission.
Exclusion criteria were previous artiﬁcial nutrition
support during hospital admission, artiﬁcial nutrition
support started at the previous institution, participants
<18 years of age or failure to obtain consent/assent due
to serious illness or lack of next of kin. Informed consent
was obtained from participants or next of kin prior to
enrolment. Study participation was for the duration of
artiﬁcial nutrition support to a maximum of 15 consecu-
tive days. All the participants were recruited within 48 h
of commencement of artiﬁcial nutrition support with
enteral or parenteral feeding. Energy prescriptions for
each participant were estimated by the dietetic specialty
who used basal metabolic rate and stress-related factors.9
The hospital nutrition policy for adults with risk factors
for refeeding syndrome was 800 kcal/day or 50% of esti-
mated adult energy requirements.
Outcome measures
The primary outcome of interest in this study was the
occurrence of refeeding syndrome. The secondary
outcome was analysis of the risk factor at predicting
refeeding syndrome. The tertiary outcome measure was
mortality due to refeeding syndrome and all-cause
mortality.
Data collection
Baseline serum electrolyte concentrations were recorded
within 24 h of study enrolment, then every third day for a
maximum of 15 days during the period of artiﬁcial nutri-
tion support. Serum electrolytes were not recorded when
artiﬁcial nutrition support was stopped. Serum electrolyte
concentrations were obtained from the hospital elec-
tronic inpatient system (iSoft, V.1.0 Oxon, England). The
normal hospital adult serum reference ranges were
potassium 3.5–5 mmol/l, phosphate 0.8–1.4 mmol/l and
magnesium 0.7–1.00 mmol/l. Body weight (kg) was mea-
sured using balance and digital scales accurate to within
0.1 kg (Seca, 22089 Hamburg, Germany) wearing light
indoor clothing. Body weight was not recorded in partici-
pants who were sedated or unconscious. Height (m) was
recorded using measured or recalled data as appropriate.
Body mass index (kg/m2) and percentage weight loss
(normal body weight—current body weight/normal
body weight ×100) were calculated. To determine which
participants had poor nutritional intake prior to artiﬁcial
nutrition support, dietary caloric intake was calculated by
Figure 1 Flow chart showing
number of participants at each
stage of the study and
stratification.
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a research assistant. Each participant was asked to recall
their dietary food and ﬂuid intake in the 10 days preced-
ing recruitment into the study. Food portion sizes were
estimated from a reference guide10 and total daily energy
intake was calculated using a nutritional analysis software
package, (Compeat, Oxon, England)11 If the participants
were unable to provide a diet history, the next of kin was
interviewed; failing this, retrospective food-intake records
were used.
Data analysis
Descriptive statistics were performed on the entire cohort
of 243 participants to obtain diagnostic data, electrolyte
supplementation and caloric intake. Each participant was
classiﬁed at risk or not at risk of refeeding syndrome as
per the diagnostic criteria displayed in table 1. Sensitivity
and speciﬁcity values for refeeding syndrome were calcu-
lated for the entire cohort of 243 participants. The preci-
sion of the sensitivity and speciﬁcity analysis was set at
70%. Predictor variables were transformed to binary cat-
egories representing whether or not refeeding syndrome
had been diagnosed. The refeeding syndrome outcomes
were analysed using Fisher’s exact test at the p<0.05 level.
A subgroup analysis of the 133 participants with risk
factors for refeeding syndrome was performed to provide
data on the secondary outcome measure of the study.
This subgroup analysis stratiﬁed these 133 participants
according to their baseline energy intake as Group 1
<800 kcal/day versus Group 2 >800 kcal/day (ﬁgure 1).
This stratiﬁcation of baseline energy intake allowed hypo-
caloric versus normal caloric intake to be analysed. There
was no further analysis of the 110 participants without
risk factors who did not develop symptoms of the syn-
drome. All data analysis was performed using SPSS V.17
(Chicago, Illinois, USA).
RESULTS
A total of 484 participants were eligible to be recruited
(ﬁgure 1). A total of 243 participants were recruited:
median age 57 years (IQR 44.0–69.0), sex 130 (53.5%)
men. There were 133 participants with risk factors for
refeeding syndrome of which 68 were men. Recruitment
locations were wards 153 (63.0%), high dependency unit
46 (18.9%) and intensive care 44 (18.1%) (table 3). In
total, 212 (87.2%) participants received enteral; 23
(9.5%) participants parenteral; and 8 (3.3%) received
enteral/parenteral tube feeding. There were 2615 total
feed days, median duration 13 days (IQR 6–15). A total of
2765 serum electrolyte results were recorded, 1014 for
potassium, 1006 for phosphate and 745 for magnesium.
The total number of participants who received electrolyte
supplementation were potassium 71, magnesium 52
and phosphate 49. Occurrence of moderate and severely
low-serum electrolyte concentration with mortality is dis-
played in table 4. Mortality was not attributed to refeed-
ing syndrome either during feeding (5.3%, 13/243) or
hospital admission (28%, 68/243). Cause of death in
these participants was due to underlying disease with
mortality by location: ward 45/153, high dependency
unit 14/46 and intensive care 9/44.
Using the criteria in table 2 the research team con-
ﬁrmed the diagnosis of refeeding syndrome in three par-
ticipants, asymptomatic electrolyte depletion in two
participants and the remaining 238 participants did not
develop symptoms. Poor nutritional intake for more than
10 days, weight loss >15% prior to recruitment and a low-
serum magnesium level at baseline had sensitivity values
of 66.7%. By contrast, all speciﬁcity values were high
(>80%) apart from weight loss >15%, which had a speciﬁ-
city of 59.1%. Low baseline serum magnesium (p=0.021)
independently predicted refeeding syndrome: other
independent variables were not signiﬁcantly associated.
The pre-existing risk factors for refeeding syndrome
within groups one and two are displayed in table 5.
Characteristics of the three participants diagnosed with
refeeding syndrome are displayed in table 6. Number of
participants in the two risk groups that received electro-
lyte supplementation is displayed in table 7.
Participant diagnosed with refeeding syndrome
A 48-year-old woman presented with confusion, bilateral
leg weakness, alcohol withdrawal, poor nutritional intake
with repeat vomiting for 7 days, C2 fracture, translocation
at C2/3 and high urinary ketones. The participant
received two intravenous doses of standard vitamins B
and C formulation in 0.9% NaCl followed by 100 mg oral
thiamine. On day 2, the patient received 1 litre of intra-
venous potassium chloride and 2 litres of 5% glucose fol-
lowed by enteral tube feeding. On day 3, serum
phosphate was recorded at 0.33 mol/l and 50 mmol/l
intravenous phosphate in 500 ml was infused over 12 h.
On day 4, the participant developed peripheral oedema
with tachycardia and was transferred to the intensive care
unit due to respiratory failure and acute circulatory ﬂuid
overload.
Another participant, a 23-year-old woman, with
Crohn’s disease and subtotal bowel colectomy presented
with frontal occipital headaches radiating to the neck
with a history of nausea, vomiting and weight loss of
26 kg. At day 117 of admission, a nasogastric tube was
inserted owing to poor nutritional intake. Nutrition was
stopped within 2 h owing to vomiting and abdominal
pain. The participant collapsed 24 h later due to hypo-
tension, hypothermia, dehydration and pseudobowel
obstruction. The participant was transferred to the high-
dependency unit for ﬂuid resuscitation. Intravenous 10%
glucose was started, and a 16 French wide bore nasogas-
tric tube was inserted for gastric drainage. On day 2,
serum electrolytes levels were potassium 3.2 mmol/l,
phosphate 0.26 mmol/l and magnesium 0.55 mmol/l.
Intravenous phosphate replacement was started with
50 mmol/l phosphate in 500 ml. The participant was
transferred to the intensive care unit, intubated and
started on haemoﬁltration owing to multiorgan failure.
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Another participant, a 31-year-old woman, with decom-
pensated liver cirrhosis secondary to alcohol, with exist-
ing chronic pancreatitis and opiate dependency with a
weekly alcohol intake of 56 units was admitted to the
hepatology unit with abdominal pain, vomiting and dehy-
dration. Usual body weight was 48 kg; admission dry
weight was 40 kg. The participant received a standard for-
mulation of vitamins B and C followed by 1 litre of 5%
glucose containing 20 mmol/l KCl. Oral thiamine
100 mg and oral vitamin B compound were prescribed.
The participant had a nasogastric tube inserted for artiﬁ-
cial nutrition support. On day 3, serum electrolytes were
potassium 2.5 mmol/l, phosphate 0.37 mmol/l and mag-
nesium 0.56 mmol/l. The participant developed acute
circulatory ﬂuid overload and symptoms of tachycardia
and pneumonia. The participant was given 50 mmol/l
intravenous phosphate in 500 ml infused over 12 h in
1 litre of 5% glucose, 25 mmol magnesium and a repeat
intravenous dose of a standard vitamin B and C
formulation.
DISCUSSION
This study applied a three facet diagnostic criteria to
conﬁrm the occurrence of refeeding syndrome in adults
started on artiﬁcial nutrition support. This unequivocal
clinical diagnostic criteria comprised of deﬁned severe
serum electrolyte concentrations, acute circulatory ﬂuid
overload and organ dysfunction. These symptoms
occurred within 72 h of hypocaloric artiﬁcial nutrition
Table 3 Cohort information, diagnostic data, supplementation totals and energy intake (n=243)
Factor
Location
Ward (n=153) HDU (n=46) ICU (n=44)
Male 78 25 27
Female 75 21 17
Age
Median 62.0 53.0 52.5
IQR 47.0–73.0 39.0–67.5 41.0–61.7
Diagnostic categories
Neurological 39 20 16
Respiratory 6 5 2
Trauma 6 0 0
Medicine 9 0 0
Hepatology 25 2 10
Renal 8 1 0
Pancreas 9 0 1
Gastroenterology 6 3 4
Cancer 13 2 0
Cardiovascular 22 9 4
Surgical 7 1 5
Sepsis 3 3 2
Length of stay (days)
Median 28.5 38.0 29.5
IQR 17.0–47.5 17.0–67.5 20.5–42.7
Electrolyte supplementation totals
Potassium 72 29 37
Phosphate 48 24 21
Magnesium 46 28 35
B vitamin supplementation
Totals 43 10 8
Duration of artificial nutrition (days)
Median 10.5 15.0 15.0
IQR 5.0–15.0 9.5–15.0 12.3–15.0
Energy intake kcal /day
Baseline
Median (IQR) 675 (390–1300) 690 (480–1000) 760 (420–1124)
Day 3
Median (IQR) 1113 (848–1600) 1440 (1120–1606) 1470 (1005–1809)
Day 6
Median (IQR) 1547 (1094–1850) 1500 (1292–1826) 1370 (965–1750)
Day 9
Median (IQR) 1500 (900–1877) 1449 (960–1700) 1590 (1200–1907)
HDU, high dependency unit; ICU, intensive care unit; IQR, IQR at 25th and 75th centiles.
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support in three participants identiﬁed at risk. Two parti-
cipants developed respiratory failure and multiorgan
failure and required admission to the intensive care unit
while the third participant, who developed acute circula-
tory ﬂuid overload and tachycardia, was treated on the
ward. The survival of these three participants represents
advances in the medical management of severely mal-
nourished individuals compared with the fatal outcome
of early reports.2 5 This study does not support previous
reports that refeeding syndrome can be prevented by
identiﬁcation of risk and treatment with hypocaloric
feeding. In this study, refeeding syndrome occurred in
three participants who had been identiﬁed at risk and
treated with hypocaloric feeding. Risk factors distinct to
the three refeeding syndrome participants were a history
of starvation and baseline low-serum magnesium concen-
tration. Two of the three participants received an intra-
venous dose of standard vitamins B and C formulation,
prior to artiﬁcial nutrition support which may have pre-
vented Wernicke’s encephalopathy. The small number of
participants diagnosed with refeeding syndrome in this
study may have been due to the medical teams having a
policy of early electrolyte replacement. However, we
suspect that the most compelling reason for the low
occurrence of refeeding syndrome, in this study, was that
starvation was a characteristic of only three participants.
The analysis of the two subgroups showed strikingly
similar malnutrition proﬁles but substantially different
energy intakes. We interpret this to suggest that for the
refeeding syndrome to occur a risk factor was required.
The compelling risk factor of the three diagnosed partici-
pants was starvation. This interpretation is supported by
the analysis of those participants who reported a short
period of fasting, prior to artiﬁcial nutrition support, and
experienced moderate falls in their serum electrolyte
concentrations.
Strengths and weaknesses of the study
The results of this study should be interpreted with
caution. The study was not designed to assess the mechan-
ism of the refeeding syndrome. The strengths of the study
were standardised diagnostic criteria, risk factor analysis
and comparison of the hypocaloric and normal caloric
nutrition groups. The results have limited external validity
Table 4 Moderately and severely low-serum electrolyte values with mortality (total participants=243)
Number of electrolyte
values recorded
Number of
moderately low values Mortality
Number of
severely low values Mortality
Potassium <3.4 mmol/l <2.5 mmol/l
Baseline (n 243) 20 0 1 0
Day 3 (n 226) 22 0 3 0
Day 6 (n 180) 11 0 0 0
Day 9 (n 152) 7 1 1 0
Phosphate <0.5 mmol/l <0.32 mmol/l
Baseline (n 243) 7 1 3 0
Day 3 (n 222) 15 3 1 0
Day 6 (n 177) 4 0 0 0
Day 9 (n 151) 2 0 0 0
Magnesium <0.6 mmol/l <0.5 mmol/l
Baseline (n 243) 14 0 5 0
Day 3 (n 164) 5 0 2 0
Day 6 (n 132) 4 0 2 0
Day 9 (n 112) 5 0 3 0
Normal hospital reference ranges potassium 3.5–5.0 mmol/l, phosphate 0.8–1.4 mmol/l and magnesium 0.7–1.00 mmol/l.
Table 5 Malnutrition profiles of the two groups
Risk factors
Group 1 Hypocaloric nutrition
<800 kcal/day at baseline (n=32)
Group 2 Normal nutrition
>800 kcal at baseline (n=101) Totals
BMI<(16 kg/m2) 6 4 10
BMI<(14 kg/m2) 1 1 2
Weight loss >15% 16 9 25
within the previous 3–6 months
Poor nutritional intake >10 days 20 15 35
Low baseline serum electrolyte
concentrations
Potassium <3.5 mmol/l 14 6 20
Phosphate <0.8 mmol/l 20 14 34
Magnesium <0.7 mmol/l 11 10 21
Figures are totals within each group.
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due to the inherent bias of narrow selection criteria. This
selection bias effect and exclusion of participants who
were able to take oral nutritional intake may explain the
low occurrence of the refeeding syndrome recorded in the
study population. A large number of potentially eligible
participants could not be recruited due to difﬁculty in
obtaining consent. A further reduction in potential partici-
pants was death within 24 h of commencing artiﬁcial nutri-
tion support. The causes of death in these participants
were due to their underlying medical condition of cere-
brovascular accident, traumatic injury, respiratory failure
due to degenerative neurological disease, organ failure or
end-of-life causes. Since death occurred within 24 h of
starting artiﬁcial nutrition support, we cannot exclude
complications of refeeding syndrome as a contributing
factor. Confusion, communication impairment and
cognitive problems due to refeeding syndrome may also
explain why a large number of severely ill individuals
refused participation in this cohort study. Equally valid is
the possibility that these severely ill individuals refused par-
ticipation due to the limited beneﬁt inclusion in this study
would provide.
The diagnosis of only three participants limited the
statistical analyses that we could perform which excluded
regression analyses. The low occurrence of refeeding syn-
drome may have been due to the medical teams taking
preventative actions such as early electrolyte replacement.
Severely low electrolyte concentrations may be inter-
preted as too low to conﬁrm the syndrome. However, the
serum electrolyte concentrations were obtained from a
review of the evidence to enable an unequivocal diagno-
sis of the refeeding syndrome. This discreet approach was
taken to avoid falsely diagnosing participants with single,
abnormal electrolyte concentrations. While the review of
evidence was consistent for severely low-serum electrolyte
concentrations, the authors identiﬁed a lack of consensus
on the electrolyte concentration values to diagnose the
syndrome. To avoid bias, the authors were not involved in
nutritional treatment, electrolyte supplementation or
initial diagnosis of the syndrome.
Interpretation
Occurrence of serum phosphate <0.5 mmol/l in this
study was 3% on day 1 and 6% on day 3 which was higher
than that reported in the adult hospital population of
0.2–2%.7 8 12 13 The higher occurrence of hypophospha-
taemia in this study may have been due to the cohort con-
taining participants recruited from the high dependency
and intensive care units. Very few participants developed
severe electrolyte shifts, although moderate serum con-
centrations of potassium, phosphate and magnesium
occurred. The interpretation of moderate electrolyte
shifts, without symptoms of the syndrome, was cellular
uptake of electrolytes in response to nutritional input.
The subgroup analysis identiﬁed many participants with
Table 6 Characteristics of the three participants confirmed with refeeding syndrome
Participant x Participant y Participant z
Age (years) 48 23 31
Diagnostic group Trauma Gastroenterology Hepatology
Chronic condition Alcoholism Malnutrition Alcoholism
Route of artificial nutrition support Enteral Enteral Enteral
Baseline received energy (kcal/day) 800 294 325
Baseline energy (kcal/kg) 12.7 6.3 8.1
Potassium replacement Yes Yes Yes
Phosphate replacement Yes Yes Yes
Magnesium replacement No No Yes
Body weight/kg 63 47 40
BMI (kg/m2) 20 16 16
Intravenous carbohydrate Yes Yes Yes
Survival outcome Survived Survived Survived
BMI, body mass index.
Table 7 Number of participants in the two risk groups
that received electrolyte supplementation
Group 1 Hypocaloric
nutrition
<800 kcal/day at
baseline (n=32)
Group 2 Normal
nutrition >800 kcal
at baseline (n=101)
Baseline
Potassium 28 22
Phosphate 21 19
Magnesium 20 20
Day 3
Potassium 8 34
Phosphate 6 30
Magnesium 5 32
Day 6
Potassium 8 34
Phosphate 5 30
Magnesium 7 32
Day 9
Potassium 4 27
Phosphate 5 22
Magnesium 3 21
Rio A, Whelan K, Goff L, et al. BMJ Open 2013;3:e002173. doi:10.1136/bmjopen-2012-002173 7
Prospective cohort study of refeeding syndrome in adults
 group.bmj.com on March 26, 2014 - Published by bmjopen.bmj.comDownloaded from 
risk factors for the syndrome. Hypocaloric nutritional
treatment may have prevented refeeding syndrome in
some of these participants. However, the subgroup ana-
lysis revealed that one group received more energy
sooner and for longer but did not develop symptoms.
Applying the diagnostic criteria in table 2 revealed the
risk factors3 to be weak predictors of the syndrome.
The impact of intravenous glucose infusion, without
adequate and repeated electrolyte replacement in the
three diagnosed participants, cannot be under estimated.
In starved individuals gluconeogenesis is the predominant
metabolic pathway for energy production. Infusion of
intravenous glucose potentially suppressed gluconeogen-
esis which caused a switch to glycolysis in these three
participants. This switch caused insulin to be released
causing rapid cellular uptake of serum phosphate, potas-
sium and magnesium electrolytes. We propose that the
initial infusion of glucose in the three starved participants
potentially triggered the metabolic sequence that resulted
in development of the syndrome. Hypocaloric feeding
failed to prevent refeeding syndrome in these three parti-
cipants for one important reason, it continued the input
of simple carbohydrates causing more insulin to be
released. This explanation is supported by other studies
where intravenous glucose infusion was attributed to hypo-
phosphataemia of <0.7 mmol/l14 which progressed to
respiratory failure at serum phosphate concentration 0.2–
0.36 mmol/l.15–17 The results of the present study indicate
that glucose infusion should be avoided in starved indivi-
duals who require ﬂuid and nutritional treatment. The
ﬁnding that intravenous glucose infusion in starved indivi-
duals may initiate the refeeding syndrome requires further
research. A potential hypothesis to be tested is that electro-
lyte replacement strategies are more effective at preventing
the syndrome than caloric restriction.
Comparison with other studies
The era of hypercaloric feeding in cachectic individuals
was associated with cardiac abnormalities,18 respiratory
failure and death.5 Two decades later, controlled hypocalo-
ric nutritional treatment and electrolyte supplementation
prevented refeeding syndrome in eight prisoners who had
been on hunger strike for 43 days.19 Under controlled con-
ditions, hypocaloric nutritional treatment and intravenous
phosphate containing 25 mmol/l over 12 h with efferves-
cent oral phosphate (16 mmol) twice daily prevented
serious complications associated with refeeding syndrome
in a 30-year-old man who endured 44 days of self-imposed
starvation.20 Refeeding syndrome was prevented in 29
anorexia nervosa participants given 500–2000 mg phos-
phate daily.21 The energy prescription was 1900 kcal at day
1 and 2200 kcal at day 3 yet moderate hypophosphataemia
(0.31–0.8 mmol/l) did not occur. These varied studies
reﬂect increased awareness of the syndrome where serious
complications and mortality can be avoided.22 23 In the
present study, refeeding syndrome was a rare, survivable
phenomenon that occurred in starved individuals who cru-
cially were identiﬁed at risk and treated with hypocaloric
nutrition.24 However, intravenous glucose infusion prior to
artiﬁcial nutrition support may have triggered the onset of
refeeding syndrome.
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